Bionet-asia Co., Ltd.

This study tests the safety of a new whooping cough (pertussis) vaccine in about 2,400 healthy adults aged 18 to 75. Participants receive a single booster dose, and researchers watch for side effects over 28 days. The goal is to confirm the vaccine is safe and to check that diffe…

This study looks back at medical records of 2,700 pregnant women in Thailand who received the Pertagen® whooping cough vaccine and their babies. Researchers want to see if the vaccine is linked to any delivery problems or health issues in newborns. No new treatments are given—jus…